Spruce Biosciences (NASDAQ:SPRB) Q3 Loss Widens as TA-ERT BLA Remains on Track
Spruce Biosciences Establishes Adrenyx Subsidiary to Develop CAH Treatment CRHX-101
Spruce Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
Spruce Biosciences Announces Separation of CRHX-101 (Formerly SPR-202) Program into Adrenyx Biosciences
Spruce Biosciences Q3 EPS $(8.51) Up From $(14.58) YoY
Spruce Biosciences Separates CRHX-101 Program Into Adrenyx Biosciences, Plans Spin-Off To Stockholders
Spruce Biosciences to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
Spruce Biosciences to Participate in the Craig-Hallum Biotech Catalyst Conference
Spruce Biosciences Announces Presentation of MPS IIIB Natural History Data at the 55th Child Neurology Society Annual Meeting
Citizens Reiterates Market Outperform on Spruce Biosciences, Maintains $144 Price Target
Lake Street Initiates Coverage On Spruce Biosciences with Buy Rating, Announces Price Target of $149
Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Spruce Biosciences stock gains after analyst backs regulatory progress
Spruce Biosciences Announces Launch of MPS3BStudy.com
Spruce Biosciences Launches MPS3BStudy.com, Online Resource For Families And Caregivers Of Children With Sanfilippo Syndrome Type B
Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
Guggenheim Maintains Buy on Spruce Biosciences, Lowers Price Target to $104
Citizens Maintains Market Outperform on Spruce Biosciences, Lowers Price Target to $144
Spruce Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Cure Sanfilippo Foundation and National MPS Society Make $5.5 Million Strategic Investment in Spruce Biosciences
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.